2012
DOI: 10.1016/j.cca.2011.12.022
|View full text |Cite
|
Sign up to set email alerts
|

Clinical performance of the carbohydrate-deficient transferrin (CDT) assay by the Sebia Capillarys2 system in case of cirrhosis. Interest of the Bio-Rad %CDT by HPLC test and Siemens N-Latex CDT kit as putative confirmatory methods

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
25
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 17 publications
(27 citation statements)
references
References 19 publications
2
25
0
Order By: Relevance
“…Di-tri bridging was originally observed in the laboratory without detailed clinical data, and was hypothesized to represent a genetic variant (Helander et al, 2001). Although genetic variation could contribute to this pattern, in subsequent case reports it has been associated with significant liver disease (Arndt et al, 2008;Stewart et al, 2010;Gonzalo et al, 2012). The current study confirmed and extended these observations.…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…Di-tri bridging was originally observed in the laboratory without detailed clinical data, and was hypothesized to represent a genetic variant (Helander et al, 2001). Although genetic variation could contribute to this pattern, in subsequent case reports it has been associated with significant liver disease (Arndt et al, 2008;Stewart et al, 2010;Gonzalo et al, 2012). The current study confirmed and extended these observations.…”
Section: Discussionsupporting
confidence: 83%
“…Despite its utility in identifying chronic heavy drinking, CDT assay methods have diminished specificity for heavy alcohol use in patients with liver disease and particularly cirrhosis (Heinemann et al, 1998;DiMartini et al, 2001). Case series using the relatively newer HPLC or capillary electrophoresis assays for %dCDT have shown that liver disease can be associated with a diminished chromatographic resolution of disialotransferrin from trisialotransferrin (Arndt et al, 2008;Stewart et al, 2010;Gonzalo et al, 2012), which is the likely cause of this diminished specificity for heavy drinking. This abnormal pattern is due to the presence of higher mass disialotransferrin isoforms resulting from liver-diseaseassociated changes in transferrin glycosylation (Landberg et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…The transferrin glycoform patterns in serum samples from our patients with alcohol dependency and healthy subjects were similar to those in previous reports [20,25,26]. In patients with liver cirrhosis or NASH, the disialotransferrin levels were the same as those in healthy subjects.…”
Section: Discussionsupporting
confidence: 87%
“…78 Our results indicate very a similar performance in a smaller cohort. 71 A sensitivity of 86% with a specificity of 94% was observed for a chronic alcohol consumption higher than 60 g/day, and no significant CDT elevation was observed for daily alcohol consumption lower than 30 g/day.…”
Section: Gonzalo Et Almentioning
confidence: 92%
“…71 In contrast to other glycoproteins, the lack of sialic acid residues in CDT isoforms does not cause their accelerated hepatic clearance via the asialoglycoprotein receptor. 63 Thus, CDT isoforms can accumulate at the plasma level, which is not the case for other serum glycosylated proteins that, as a result, cannot be used as biomarkers of heavy drinking.…”
Section: Gonzalo Et Almentioning
confidence: 98%